Publications by authors named "David Ebel"

Claim this Profile
S
Single therapeutic and supratherapeutic doses of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, do not prolong the QTcF interval in healthy volunteers.
Wen-Lin Luo, Tami Crumley, David Ebel, George J Atiee, Jane Royalty

J Clin Pharmacol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the tolerability of recombinant human hyaluronidase + normal saline and recombinant human hyaluronidase + lactated ringer's solution administered subcutaneously: A phase IV, double-blind, randomized pilot study in healthy volunteers.
Samuel S Dychter, David Ebel, Tonya R Mead, Richard C Yocum

Curr Ther Res Clin Exp· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.
Victor Dishy, Fang Liu, David L Ebel, George J Atiee, Jane Royalty

J Clin Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of antacids on single-dose pharmacokinetics of etoricoxib.
Jules I Schwartz, Nancy G B Agrawal, Uma A Kher, Marina DeSmet, Paul F Cavanaugh, David L Ebel

J Clin Pharmacol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
Arthur Bergman, David Ebel, Fang Liu, Julie Stone, Amy Wang

Biopharm Drug Dispos· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C]sitagliptin in humans.
Stella H Vincent, James R Reed, Arthur J Bergman, Charles S Elmore, Bing Zhu, David Ebel

Drug Metab Dispos· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of rofecoxib on prednisolone and prednisone pharmacokinetics in healthy subjects.
Jules I Schwartz, Saurabh Mukhopadhyay, Arturo G Porras, Kala-Jyoti Viswanathan-Aiyer, Sherilyn Adcock, David L Ebel

J Clin Pharmacol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of rofecoxib on the pharmacokinetics of chronically administered oral contraceptives in healthy female volunteers.
Jules I Schwartz, Peggy H Wong, Arturo G Porras, David L Ebel, Thomas R Hunt

J Clin Pharmacol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis